Mechanism of action
Carbon dioxide exerts its physiological effects through multiple mechanisms. As a respiratory stimulant, CO₂ acts directly on the medullary respiratory center in the brainstem, where chemoreceptors in the ventrolateral medulla detect increases in PaCO₂ and decreases in pH. This triggers increased ventilatory drive through both central and peripheral chemoreceptors.
CO₂ is a potent cerebral vasodilator, increasing cerebral blood flow by causing relaxation of vascular smooth muscle through local acidosis (CO₂ + H₂O ↔ H₂CO₃ ↔ H⁺ + HCO₃⁻). This pH-mediated vasodilation also affects systemic vessels. At the cellular level, CO₂ diffuses rapidly across cell membranes and alters intracellular pH, affecting numerous enzymatic processes.
During laparoscopic insufflation, CO₂ creates a pneumoperitoneum by distending the abdominal cavity, providing surgical visualization and working space. CO₂ is preferred over other gases because it is highly soluble in blood (reducing embolic risk), non-flammable, and readily eliminated by the lungs. However, peritoneal absorption leads to systemic effects including hypercarbia and acidosis.
- CO₂ is the insufflation gas of choice for laparoscopy because it is highly soluble in blood, reducing gas embolism risk, and non-flammable.
- Peritoneal CO₂ absorption during laparoscopy causes hypercarbia and respiratory acidosis; compensate by increasing minute ventilation 10-20%.
- Hypercarbia (PaCO₂ >50-60 mmHg) sensitizes the myocardium to catecholamines, increasing arrhythmia risk under volatile anesthetics.
- CO₂ embolism presents with sudden drop in ETCO₂ (not rise), hypotension, and mill-wheel murmur; treat with Durant maneuver.
- CO₂ is a potent cerebral vasodilator; avoid in patients with increased intracranial pressure.
- Shoulder pain after laparoscopy results from residual CO₂ irritating the diaphragm (C3-5 referred pain).
- ETCO₂ underestimates PaCO₂ during laparoscopy due to increased V/Q mismatch; the gradient widens from baseline 2-5 mmHg.
- CO₂ narcosis occurs when PaCO₂ exceeds 70-80 mmHg, causing confusion and CNS depression.
Indications
The primary medical uses of carbon dioxide include:
Surgical insufflation
- Laparoscopic surgery (cholecystectomy, appendectomy, gynecologic procedures)
- Endoscopic procedures (colonoscopy, arthroscopy)
- Creates pneumoperitoneum or pneumothorax for surgical visualization
Respiratory stimulation (largely historical)
- Postoperative hypoventilation (rarely used)
- Carbon dioxide/oxygen mixtures (carbogen) for respiratory depression
- Largely replaced by mechanical ventilation and modern respiratory support
Diagnostic applications
- Cerebral blood flow studies (CO₂ reactivity testing)
- Pulmonary function testing (diffusion capacity measurements)
Other medical uses
- Cryotherapy (solid CO₂/dry ice for dermatologic lesions)
- Contrast agent in angiography (historical)
Today, the overwhelming majority of medical CO₂ use is for laparoscopic and endoscopic insufflation, where it has become the standard of care.
Pharmacokinetics
Carbon dioxide exhibits unique pharmacokinetic properties as an endogenous gas:
Absorption: During laparoscopic insufflation, CO₂ is absorbed across the peritoneum into the systemic circulation. Absorption rate depends on insufflation pressure, duration of procedure, and peritoneal surface area. Peak absorption typically occurs during the first 30-60 minutes of insufflation.
Distribution: CO₂ distributes rapidly throughout body tissues due to its high lipid solubility and small molecular size. It readily crosses the blood-brain barrier and placenta. In blood, CO₂ exists in three forms: dissolved (5-10%), bound to hemoglobin as carbamino compounds (20-30%), and as bicarbonate ion (60-70%).
Metabolism: CO₂ is the end product of cellular aerobic metabolism. The body produces approximately 200-250 mL/min of CO₂ at rest. Carbonic anhydrase catalyzes the reversible hydration of CO₂ to carbonic acid in red blood cells.
Elimination: Pulmonary elimination is the primary route. The lungs excrete CO₂ with an elimination half-life of approximately 2-5 minutes under normal conditions. Minute ventilation increases proportionally to maintain PaCO₂ homeostasis. During laparoscopy, increased CO₂ production from absorbed insufflation gas is compensated by increased alveolar ventilation (in spontaneously breathing patients) or adjusted mechanical ventilation parameters.
Adverse effects
Carbon dioxide can cause significant adverse effects, particularly during prolonged laparoscopic insufflation:
Respiratory effects
- Hypercarbia: Elevated PaCO₂ from peritoneal absorption or inadequate ventilation
- Respiratory acidosis: pH decreases as CO₂ accumulates
- Increased respiratory rate and work of breathing (spontaneous ventilation)
- Bronchospasm (rare)
Cardiovascular effects
- Arrhythmias (particularly with PaCO₂ >50-60 mmHg)
- Myocardial depression at high CO₂ levels
- Increased sympathetic tone initially, followed by depression
- Hypotension from systemic vasodilation
- Decreased venous return from increased intra-abdominal pressure
Neurological effects
- Increased intracranial pressure (cerebral vasodilation)
- Confusion, disorientation at high levels
- Narcosis (CO₂ narcosis) when PaCO₂ exceeds 70-80 mmHg
- Headache
Gas embolism
- Venous gas embolism from inadvertent intravascular injection (rare)
- Can cause cardiovascular collapse if large volume
- CO₂ emboli dissolve more rapidly than air emboli
Subcutaneous/surgical emphysema
- Extraperitoneal gas tracking into tissue planes
- Particularly neck, chest wall, scrotum
- Usually self-limiting
Other effects
- Pneumothorax, pneumomediastinum (rare complications)
- Shoulder pain (referred pain from diaphragmatic irritation)
- Peritoneal irritation
Contraindications and warnings
Absolute contraindications (for insufflation use):
- None universally absolute, but relative contraindications may become prohibitive
Relative contraindications and warnings:
Severe cardiopulmonary disease
- Severe COPD with CO₂ retention
- Severe cardiac dysfunction (EF <20-25%)
- Recent myocardial infarction
- Uncontrolled arrhythmias
- Increased risk of decompensation with hypercarbia and acidosis
Intracranial pathology
- Increased intracranial pressure
- Intracranial mass lesions
- Recent neurosurgery
- CO₂-induced cerebral vasodilation worsens intracranial hypertension
Respiratory compromise
- Severe restrictive or obstructive lung disease
- Inability to tolerate increased minute ventilation requirements
- Pneumothorax (for pneumoperitoneum)
Pregnancy considerations
- Laparoscopy can be performed in pregnancy with careful monitoring
- Maintain normocapnia; avoid hypercarbia (fetal acidosis risk)
- Generally considered compatible with pregnancy when medically necessary
Other warnings
- Avoid excessive insufflation pressures (typically <15 mmHg)
- Prolonged procedures increase absorption and systemic effects
- Monitor end-tidal CO₂ continuously during laparoscopy
- Patients with severe hypovolemia may not tolerate hemodynamic effects
- Bowel distension or perforation increases peritoneal surface area and absorption
Drug interactions
Carbon dioxide has limited classical drug interactions but important physiological interactions:
Anesthetic agents
- Volatile anesthetics: CO₂ can potentiate myocardial depression
- Most inhalational agents sensitize myocardium to catecholamines; hypercarbia increases arrhythmia risk
- Nitrous oxide: avoid mixing with CO₂ for insufflation (displacement risk)
Neuromuscular blocking agents
- Hypercarbia may prolong duration of action of some neuromuscular blockers
- Respiratory acidosis shifts drug ionization and distribution
Sympathomimetics
- Initial hypercarbia increases endogenous catecholamine release
- Additive effects with exogenous vasopressors
- Increased arrhythmia risk when combined with CO₂ retention
Carbonic anhydrase inhibitors
- Acetazolamide and related agents affect CO₂/bicarbonate equilibrium
- May alter acid-base compensation during CO₂ absorption
Respiratory depressants
- Opioids, benzodiazepines, barbiturates reduce ventilatory response to CO₂
- Increased risk of severe hypercarbia if ventilation not mechanically controlled
- Blunted compensatory hyperventilation response
Clinical significance: Most interactions relate to the physiological effects of hypercarbia rather than direct pharmacological interactions. Careful monitoring of ventilation, acid-base status, and cardiovascular parameters is more important than specific drug avoidance.
Clinical pearls
Laparoscopic insufflation pearls
- End-tidal CO₂ (ETCO₂) underestimates PaCO₂ by 2-5 mmHg normally, but the gradient widens during CO₂ insufflation due to increased dead space and V/Q mismatch
- Increase minute ventilation by 10-20% prophylactically at the start of pneumoperitoneum
- Steep Trendelenburg position worsens hypercarbia by impairing diaphragmatic excursion
- Desufflation at procedure end leads to rapid decrease in PaCO₂ within 5-10 minutes
CO₂ embolism recognition
- Classic triad: sudden decrease in ETCO₂, hypotension, and mill-wheel murmur
- ETCO₂ drop occurs because CO₂ is trapped in right heart rather than reaching lungs
- Place patient in left lateral decubitus and Trendelenburg (Durant maneuver) if suspected
- CO₂ emboli resolve faster than air emboli due to high blood solubility
Acid-base considerations
- Hypercarbia causes respiratory acidosis: pH falls 0.08 for every 10 mmHg rise in PaCO₂ acutely
- Renal compensation (increased bicarbonate retention) takes 3-5 days
- During laparoscopy, metabolic acidosis may develop from splanchnic hypoperfusion (increased intra-abdominal pressure)
Special populations
- COPD patients: accept higher baseline PaCO₂; avoid over-correction
- Morbidly obese patients: increased baseline CO₂ production and absorption; use lower insufflation pressures
- Pediatric patients: faster peritoneal absorption relative to body size; monitor closely
Exam high-yield associations
- CO₂ versus air for insufflation: CO₂ chosen because it is highly blood-soluble, reducing embolism severity
- Shoulder pain after laparoscopy: referred pain from residual CO₂ irritating diaphragm (C3-5 innervation)
- Hypercarbia sensitizes myocardium to catecholamines → arrhythmias under volatile anesthetics
Practice questions
1. A 58-year-old woman undergoes laparoscopic cholecystectomy under general anesthesia with sevoflurane. Thirty minutes into the procedure, the anesthesiologist notes an end-tidal CO₂ of 48 mmHg (baseline 35 mmHg) and frequent premature ventricular contractions on the monitor. Blood pressure is 110/70 mmHg and heart rate is 95/min. Which of the following best explains the arrhythmia?
2. During a laparoscopic appendectomy, the surgical team notes a sudden decrease in end-tidal CO₂ from 38 mmHg to 18 mmHg, accompanied by hypotension (BP 75/40 mmHg) and oxygen desaturation. A mill-wheel murmur is auscultated over the precordium. Which of the following is the most appropriate immediate management?
3. A 72-year-old man with severe COPD (baseline PaCO₂ 58 mmHg) requires urgent laparoscopic surgery. During the procedure under general anesthesia, which of the following monitoring strategies is most appropriate for managing his ventilation?
Frequently asked questions
How does carbon dioxide work as a medical gas?
Carbon dioxide stimulates the medullary respiratory center directly, increasing ventilatory drive through central and peripheral chemoreceptors that sense PaCO₂ and pH changes. It also acts as a potent vasodilator by lowering pH in smooth muscle, increasing cerebral and systemic blood flow. During laparoscopic surgery, CO₂ is used to insufflate the abdomen, creating working space while being rapidly absorbed and eliminated by the lungs.
What are the side effects of carbon dioxide during laparoscopy?
The main side effects include hypercarbia (elevated blood CO₂), respiratory acidosis, cardiac arrhythmias (especially with PaCO₂ >50-60 mmHg), hypotension from vasodilation, and increased intracranial pressure. Subcutaneous emphysema can occur if gas tracks into tissue planes. Shoulder pain from diaphragmatic irritation is common postoperatively. Rare but serious complications include CO₂ embolism causing cardiovascular collapse and pneumothorax.
Why is carbon dioxide used instead of air for laparoscopy?
CO₂ is preferred over air or other gases because it is highly soluble in blood (about 20 times more soluble than nitrogen), which means that if venous gas embolism occurs, CO₂ emboli dissolve much faster and cause less severe complications. CO₂ is also non-flammable, eliminating fire risk during electrosurgery, and is readily eliminated by the lungs through normal respiration. These safety advantages make it the standard insufflation gas.
How is carbon dioxide eliminated from the body?
CO₂ is primarily eliminated through the lungs via exhalation, with an elimination half-life of approximately 2-5 minutes under normal ventilation. During laparoscopy, absorbed peritoneal CO₂ enters the bloodstream, is transported to the lungs (mostly as bicarbonate, with smaller amounts dissolved or bound to hemoglobin), and is exhaled. Increased minute ventilation compensates for the additional CO₂ load. After desufflation, PaCO₂ returns to baseline within 5-10 minutes.
What is CO₂ narcosis and when does it occur?
CO₂ narcosis is central nervous system depression that occurs when PaCO₂ rises above approximately 70-80 mmHg, causing confusion, disorientation, lethargy, and potentially loss of consciousness. It results from severe respiratory acidosis affecting neuronal function. CO₂ narcosis is most commonly seen in patients with chronic CO₂ retention (severe COPD) who receive supplemental oxygen without adequate ventilation, or during prolonged laparoscopy with inadequate minute ventilation. Treatment involves improving ventilation to lower PaCO₂.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: V03AN02
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.